NEW YORK & BOULDER, Colo.--(BUSINESS WIRE)-- CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, Inc., a global leader in proteomics technology, announced today that their new customizable protein ...

SomaLogic is a commercial stage proteomics company with over 300 established industry partnerships and customers. The company’s pioneering technology platform is uniquely capable of becoming a ...

BOULDER, Colo. and L’AQUILA, Italy, July 24, 2023 (GLOBE NEWSWIRE) -- SomaLogic Operating Co. Inc., (Nasdaq:SLGC), a leader in data-driven proteomics technology, today announced its partnership with ...

Founded by CU Boulder Professor Larry Gold in 2000, SomaLogic revolutionized protein measurement by developing a faster, cost-effective process to monitor the vast number of proteins in the human body ...

Illumina is diving deeper into proteomics research with a $425 million plan to acquire SomaLogic, including its protein analysis platforms and certified lab services business. The deal with ...

SAN DIEGO, June 23, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today it has entered into a definitive agreement with Standard BioTools (NASDAQ: LAB) under which Illumina will acquire ...

BOULDER, Colo., Sept. 05, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc. (SLGC), a leader in proteomics technology, announced today that it is extending its collaborative agreement with global healthcare ...

Illumina announced today it has entered into a definitive agreement with Standard BioTools under which Illumina will acquire SomaLogic, a leader in data-driven proteomics technology, for up to $425 ...

SomaLogic Inc., a protein-analysis bioscience company that expects to go public via a merger with special purpose acquisition company CM Life Sciences II (Nasdaq: CMIIU), has hired Shaun Blakeman as ...

Two weeks after Boulder biosciences company SomaLogic Inc. won U.S. Securities and Exchange Commission approval for its go-public merger with a special purpose acquisition company, shareholders signed ...

Transaction combines SomaLogic’s comprehensive proteomics technology platform with CM Life Sciences II, a leading life science-focused SPAC, led by affiliates of institutional investors Casdin Capital ...